Pancreatic Cancer Research

ResearcherArmy Medical UniversityNo recent work listed

Zhihua Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4820-4603; OpenAlex author ID A5100319846. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 2 papers · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers

Papers 8

  1. Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in … Co-author DOI 10.1016/j.canlet.2022.215859↗
  2. KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer. First author DOI 10.1172/jci157644↗
  3. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.13351↗
  4. The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1. First author DOI 10.1007/s13277-015-4234-0↗
  5. Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-rela… Co-author DOI 10.1016/j.canlet.2015.12.010↗
  6. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. Co-author DOI 10.1186/s12967-015-0442-z↗
  7. Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. First author DOI 10.18632/oncotarget.5533↗
  8. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer. Co-author DOI 10.1093/carcin/bgr088↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuming Luo · 4 shared papers, 2016–2022 · strength 0.38
  2. Yimin Liu · 6 shared papers, 2015–2022 · strength 0.38
  3. Shangyou Zheng · 6 shared papers, 2015–2022 · strength 0.38
  4. Xiaohui Zhao · 5 shared papers, 2015–2022 · strength 0.33
  5. Wenzhu Li · 5 shared papers, 2015–2022 · strength 0.33
  6. Wenchao Gao · 5 shared papers, 2015–2022 · strength 0.31
  7. Yingxue Wang · 4 shared papers, 2015–2022 · strength 0.27
  8. Huimou Chen · 4 shared papers, 2015–2022 · strength 0.26
  9. Quanbo Zhou · 4 shared papers, 2015–2022 · strength 0.25
  10. Huilin Ye · 4 shared papers, 2015–2022 · strength 0.25
  11. Zhiqiang Fu · 4 shared papers, 2015–2018 · strength 0.20
  12. Yanhui Jiang · 3 shared papers, 2016–2018 · strength 0.17
  13. Langping Tan · 2 shared papers, 2016–2022 · strength 0.17
  14. Rufu Chen · 2 shared papers, 2015–2022 · strength 0.16
  15. Rufu Chen · 3 shared papers, 2015–2016 · strength 0.14
  16. Changhao Chen · 1 shared paper, 2022 · strength 0.14
  17. Yao Kong · 1 shared paper, 2022 · strength 0.14
  18. Jiabin Yang · 1 shared paper, 2022 · strength 0.14
  19. Dingwen Zhang · 1 shared paper, 2022 · strength 0.14
  20. Rufu Chen · 1 shared paper, 2022 · strength 0.14
  21. Yu Zhou · 2 shared papers, 2015 · strength 0.08
  22. Chen Rufu · 1 shared paper, 2018 · strength 0.07
  23. Guolin Li · 1 shared paper, 2016 · strength 0.05
  24. Lei Zhao · 1 shared paper, 2015 · strength 0.05
  25. Jin-Long Zeng · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.